Navigation Links
Ajinomoto Co., Inc.'s Twofold Nutraceutical Solution Targets Weight Management and Sleep Quality Improvement
Date:10/11/2011

FORT LEE, N.J., Oct. 11, 2011 /PRNewswire/ -- Ajinomoto Co., Inc., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, is showcasing its patented Capsiate Natura® at the 61st Annual Obesity & Associated Conditions Symposium, in Las Vegas, NV,  October 28 -29.  

The first and only dietary supplement with natural capsinoids extracted from the CH-19 Sweet pepper, Capsiate Natura® is unique in addressing caloric output by boosting the body's metabolic rate* which is critical to overall weight management.  Glysom™, a nutraceutical sleep solution that represents the latest amino acid and sleep research, offers a holistic, side-effect free option for today's sleep quality improvement.

"The relationship between weight loss and sleep has been of increasing interest and importance to both medical researchers and practitioners," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Our safe, effective dietary supplements Capsiate Natura® and Glysom™ bridge the two areas for optimal benefit to the overall health."  

According to a recent study by Dr. Eve Van Cauter and associates at the University of Chicago, the effects of sleep loss are linked to an increase in hunger hormones and excessive caloric intake.(1) Additional research has shown that just one shortened night of sleep can increase caloric consumption by up to 500 additional calories, which equates to nearly an extra pound a week.(2)  Made from glycine, an amino acid that occurs naturally in the body, Glysom™ has been scientifically proven to promote deeper, sounder and more satisfying sleep and is particularly effective in promoting the non-REM sleep crucial to feeling refreshed in the morning*.  

"While Glysom™ can address the body's need for healthy deep sleep, Capsiate Natura® can help to increase its metabolism to burn more calories, which can be as important to weight management as diet and exercise," said Jun Tashiro, associate director of Ajinomoto U.S.A., Inc. "We look forward to presenting our unique dual nutraceutical solution to more medical professionals as this field develops."  

In addition to Capsiate Natura® and Glysom™, Ajinomoto Co., Inc. makes Natura Guard BP™, a milk protein-derived nutraceutical to help maintain healthy blood pressure levels already within the normal range*.  These products are substantiated through rigorous clinical studies and are available exclusively through medical professionals.  For more information and a complete list of healthcare professionals that carry Ajinomoto Food Ingredients' nutraceuticals, visit www.capsiatenatura.com, www.glysom.com and www.naturaguardbp.com.

About Ajinomoto Food Ingredients

Ajinomoto Food Ingredients delivers safe, effective ingredients whose functionality has been scientifically proven.  Our mission is the pursuit of better health through better nutrition.  Beginning with AJI-NO-MOTO® MSG, a highly versatile seasoning, our products have diversified to flavor seasonings (bonito, pork, chicken, and beef), sweeteners, savory sauces, enzymes, other food ingredients and nutritional supplements.  Based on the five basic tastes centering on Umami, Ajinomoto supplies ingredients with unique aroma, texture, kokumi (full-bodied taste) and nutritional functionality.  These ingredients make it possible for our customers to build strong brands and offer consumers great-tasting, nutritionally beneficial products.

About Ajinomoto Co., Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals.  For many decades, Ajinomoto has contributed to food culture and human health through wide-ranging application of amino acid technologies.  Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability.  Founded in 1909 and now operating in 26 countries, Ajinomoto had net sales of 1207.8 billion yen (14.2 billion USD) in fiscal 2010.  For more about Ajinomoto (TYO: 2802), visit www.ajinomoto.com.

Glysom™ and Capsiate Natura® clinical studies are available on request.

(1) Kristen L. K, Karine S, Plamen P, and Eve Van C. The Metabolic Consequences of Sleep Deprivation. Sleep Med Rev. 11 (2007): 163-178

(2) Benedict CHallschmid MLassen AMahnke CSchultes BSchioth HBBorn JLange T. Acute sleep deprivation reduces energy expenditure in healthy men. Am J Clin Nutr. 93(2011): 1229-36

*These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.


'/>"/>
SOURCE Ajinomoto Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
2. Ajinomoto Co., Inc. Harnesses Amino Acid Power to Improve Sleep
3. Nutraceutical Leader Announces Internal Promotions of Key Personnel
4. Reportlinker Adds Nutraceutical Market
5. Reportlinker Adds Global Nutraceuticals Industry
6. ScienceBased Health and Hoya Surgical Optics, Inc. Combine Forces to Expand Reach of Evidence-Based Nutraceuticals in Ophthalmic Market and Enhance Patient Care
7. Nutraceutical International Corporation Launches Product Featuring ChromaDexs pTeroPure™ Pterostilbene
8. HealthSport Signs Letter of Intent to Acquire "Excellent" Rated cGMP Certified Nutraceutical Manufacturing Plant
9. IMD Companies Announces Acquisition of Nutraceutical Company
10. Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
11. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Australia Glaucoma ... GlobalData,s new report, "Australia Glaucoma Surgery Devices ... on the Australia Glaucoma Surgery Devices market. The ... volume (in units) and average prices (USD) within ... report also provides company shares and distribution shares ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
(Date:12/8/2016)... INDIANAPOLIS , Dec. 8, 2016  Eli Lilly ... detailed results of its phase 3 EXPEDITION3 trial at ... (CTAD) meeting. As previously disclosed, solanezumab did not meet ... study of solanezumab initiated in people with mild dementia ... pursue regulatory submissions for solanezumab for the treatment of ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) aired ... of 2016. The program was made possible by a Pennsylvania Department of Health ... and Human Services Administration. The broadcast, Use Your Head: Properly Managing Sport ...
(Date:12/8/2016)... Islandia, NY (PRWEB) , ... December 08, 2016 ... ... company, is pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture ... published in JMIR Medical Informatics . , Results of the comparative usability ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Center has been recognized for adherence to the highest standards of trauma, ... accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , Among ...
(Date:12/8/2016)... ... 2016 , ... Vida Health, the digital health platform that pairs ... Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect ... consumers who are managing chronic conditions or simply want to improve their ...
Breaking Medicine News(10 mins):